Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Penn Medicine Amyloidosis Program
3400 Spruce StreetPhiladelphia, Pennsylvania, United States
Phone Web
The Amyloidosis Program at Penn Medicine is involved in the treatment and diagnosis of amyloidosis and the development of new drugs to treat the disease and its variants. Amyloidosis can have a variety of causes, and as a result, the Program brings together specialists from cardiology, nephrology, hematology-oncology, neurology, rheumatology, pulmonology and organ transplantation.
The team includes healthcare professionals in the following areas:
Hematology and Oncology:
Adam D. Cohen, MD
Cardiology:
Hansie M. Mathelier, MD, FACC
Neurology:
Sami L. Khella, MD; Chafic Karam, MD
Nephrology:
Laura M. Dember, MD
Related Content
-
Fred Hutchinson Cancer Research CenterFred Hutch is at the forefront of develo...
-
University of Kentucky Markey Cancer CenterThe UK Markey Cancer Center was founded ...
-
Allegheny Health Network Amyloidosis ProgramThe new Amyloidosis Program at Allegheny...
-
Dana Farber Cancer Institute – Amyloidosis ProgramThe Amyloidosis Program at Dana-Farber...
-
Multiple Myeloma and Amyloidosis Program, Cedars-SinaiThe Multiple Myeloma and Amyloidosis pro...
-
University of Iowa Hospitals and ClinicsUniversity of Iowa Hospitals & Clini...
-
The University of Kansas Health System – Center for TransplantationThe center for transplantation at The Un...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.